×
About 106,774 results

ALLMedicine™ Hepatitis C Center

Research & Reviews  49,819 results

Seroprevalence and trends of transfusion transmissible infections among retrospective b...
https://doi.org/10.1016/j.transci.2021.103132
Transfusion and Apheresis Science : Official Journal of T... Emadi B, Ghahraman Rezaieh M et. al.

Apr 13th, 2021 - Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis...

Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis W...
https://doi.org/10.14309/ajg.0000000000001267
The American Journal of Gastroenterology; Sharma S, Saraya A

Apr 12th, 2021 - Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?|2021|Sharma S,Saraya A,|

Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017.
https://doi.org/10.1111/jgh.15517
Journal of Gastroenterology and Hepatology; Hagiya H, Koyama T et. al.

Apr 10th, 2021 - The current prevalence of hepatitis C virus infection and hepatitis C virus-associated mortality in Japan falls short of the World Health Organization goal of viral hepatitis elimination by 2030. We aimed to evaluate the trends in hepatitis C viru...

Utility of serum neuropilin-1 and angiopoietin-2 as markers of hepatocellular carcinoma.
https://doi.org/10.1136/jim-2020-001744
Journal of Investigative Medicine : the Official Publicat... Abdel Ghafar MT, Elkhouly RA et. al.

Apr 9th, 2021 - This study aimed to assess the diagnostic value of two serum angiogenetic markers neuropilin-1 (NRP-1) and angiopoietin-2 (ANG-2) in patients with hepatocellular carcinoma (HCC) and their relation to tumor characteristics. 149 subjects were recrui...

Inflammation response and liver stiffness: predictive model of regression of hepatic st...
https://doi.org/10.1007/s10238-021-00708-w 10.1016/j.jpg.2014.03.001 10.1111/jvh.12578 10.1089/vim.2018.0124 10.1590/0037-8682-0427-2017 10.1189/jlb.4mr0314-141r 10.3390/cells8030274 10.1172/JCI66028.Fibrosis 10.3855/jidc.7595 10.1055/s-0036-1597816 10.5152/tjg.2018.17330 10.1016/j.cgh.2013.01.005 10.5604/16652681.1184193 10.1002/cyto.a.22348 10.3390/cells7100165 10.1007/s00011-018-1174-3 10.1007/s00535-016-1258-1 10.1053/gast.2002.33023 10.1016/j.bpg.2011.02.003 10.1016/j.cgh.2014.04.037 10.1111/jgh.14707 10.1097/MEG.0000000000000964 10.1148/rg.2016160042 10.3748/wjg.v20.i16.4787 10.1053/j.gastro.2014.03.019 10.1056/NEJMoa1512614 10.1590/s0004-2803.201800000-76 10.1053/jhep.1996.v24.pm0008690394 10.1016/j.cgh.2017.04.038 10.1186/1471-2105-12-77 10.1002/hep4.1228 10.1093/cid/ciz359 10.1111/hepr.13310 10.7326/0003-4819-149-6-200809160-00006 10.4254/wjh.v9.i1.64 10.1371/journal.pone.0195173 10.1093/toxsci/kfq134 10.1186/s12865-019-0313-0 10.1038/s41598-017-13777-3 10.2174/1871530319666181206125545 10.1590/0037-8682-0137-2018 10.1016/j.jhep.2016.12.019 10.1186/s13027-016-0070-0 10.1002/eji.201444903 10.1371/journal.pone.0175793 10.1371/journal.pone.0095614 10.1016/j.ijid.2020.04.041
Clinical and Experimental Medicine; Braz AMM, Winckler FC et. al.

Apr 9th, 2021 - Cirrhotic patients with chronic hepatitis C should be monitored for the evaluation of liver function and screening of hepatocellular carcinoma even after sustained virological response (SVR). The stage of inflammatory resolution and regression of ...

see more →

Guidelines  159 results

Hepatocellular carcinoma
https://www.nature.com/articles/s41572-020-00240-3
Nature Reviews; Llovet JM

Jan 20th, 2021 - Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepa...

Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...

Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578324/
JGH Open; Matsuura T

Oct 3rd, 2020 - The purpose of this study was to identify lifestyle risk factors, such as cigarette smoking and alcohol consumption, in relation to the development of hepatocellular carcinoma (HCC) among chronic hepatitis C patients who have achieved a sustained ...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/32931216
American Family Physician;

Sep 15th, 2020 - Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Statement.|2020||prevention & control,

see more →

Drugs  87 results see all →

Clinicaltrials.gov  52,649 results

Seroprevalence and trends of transfusion transmissible infections among retrospective b...
https://doi.org/10.1016/j.transci.2021.103132
Transfusion and Apheresis Science : Official Journal of T... Emadi B, Ghahraman Rezaieh M et. al.

Apr 13th, 2021 - Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis...

Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis W...
https://doi.org/10.14309/ajg.0000000000001267
The American Journal of Gastroenterology; Sharma S, Saraya A

Apr 12th, 2021 - Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?|2021|Sharma S,Saraya A,|

Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017.
https://doi.org/10.1111/jgh.15517
Journal of Gastroenterology and Hepatology; Hagiya H, Koyama T et. al.

Apr 10th, 2021 - The current prevalence of hepatitis C virus infection and hepatitis C virus-associated mortality in Japan falls short of the World Health Organization goal of viral hepatitis elimination by 2030. We aimed to evaluate the trends in hepatitis C viru...

Utility of serum neuropilin-1 and angiopoietin-2 as markers of hepatocellular carcinoma.
https://doi.org/10.1136/jim-2020-001744
Journal of Investigative Medicine : the Official Publicat... Abdel Ghafar MT, Elkhouly RA et. al.

Apr 9th, 2021 - This study aimed to assess the diagnostic value of two serum angiogenetic markers neuropilin-1 (NRP-1) and angiopoietin-2 (ANG-2) in patients with hepatocellular carcinoma (HCC) and their relation to tumor characteristics. 149 subjects were recrui...

Inflammation response and liver stiffness: predictive model of regression of hepatic st...
https://doi.org/10.1007/s10238-021-00708-w 10.1016/j.jpg.2014.03.001 10.1111/jvh.12578 10.1089/vim.2018.0124 10.1590/0037-8682-0427-2017 10.1189/jlb.4mr0314-141r 10.3390/cells8030274 10.1172/JCI66028.Fibrosis 10.3855/jidc.7595 10.1055/s-0036-1597816 10.5152/tjg.2018.17330 10.1016/j.cgh.2013.01.005 10.5604/16652681.1184193 10.1002/cyto.a.22348 10.3390/cells7100165 10.1007/s00011-018-1174-3 10.1007/s00535-016-1258-1 10.1053/gast.2002.33023 10.1016/j.bpg.2011.02.003 10.1016/j.cgh.2014.04.037 10.1111/jgh.14707 10.1097/MEG.0000000000000964 10.1148/rg.2016160042 10.3748/wjg.v20.i16.4787 10.1053/j.gastro.2014.03.019 10.1056/NEJMoa1512614 10.1590/s0004-2803.201800000-76 10.1053/jhep.1996.v24.pm0008690394 10.1016/j.cgh.2017.04.038 10.1186/1471-2105-12-77 10.1002/hep4.1228 10.1093/cid/ciz359 10.1111/hepr.13310 10.7326/0003-4819-149-6-200809160-00006 10.4254/wjh.v9.i1.64 10.1371/journal.pone.0195173 10.1093/toxsci/kfq134 10.1186/s12865-019-0313-0 10.1038/s41598-017-13777-3 10.2174/1871530319666181206125545 10.1590/0037-8682-0137-2018 10.1016/j.jhep.2016.12.019 10.1186/s13027-016-0070-0 10.1002/eji.201444903 10.1371/journal.pone.0175793 10.1371/journal.pone.0095614 10.1016/j.ijid.2020.04.041
Clinical and Experimental Medicine; Braz AMM, Winckler FC et. al.

Apr 9th, 2021 - Cirrhotic patients with chronic hepatitis C should be monitored for the evaluation of liver function and screening of hepatocellular carcinoma even after sustained virological response (SVR). The stage of inflammatory resolution and regression of ...

see more →

News  3,987 results

New 'Minimal Monitoring' Approach to HCV Treatment May Simplify Care
https://www.medscape.com/viewarticle/947455

Mar 14th, 2021 - A novel minimal monitoring (MINMON) approach to hepatitis C virus (HCV) treatment was safe and achieved sustained virology response (SVR) compared to current clinical standards in treatment-naive patients without evidence of decompensated cirrhosi...

Hepatocellular carcinoma
https://www.nature.com/articles/s41572-020-00240-3
Nature Reviews; Llovet JM

Jan 20th, 2021 - Liver cancer remains a global health challenge, with an estimated incidence of >1 million cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ~90% of cases. Infection by hepatitis B virus and hepa...

US Supreme Court Rebuffs Merck Appeal in Hepatitis C Patent Fight With Gilead
https://www.medscape.com/viewarticle/944303

Jan 19th, 2021 - (Reuters) - The U.S. Supreme Court on Tuesday rejected Merck & Co Inc's bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences Inc for infringing a patent in a dispute over a blockbuster hepatitis C treatment. Th...

Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
https://www.medscape.com/viewarticle/944180

Jan 14th, 2021 - In an effort to counteract alarming trends in rising hepatitis infections, the U.S. Department of Health and Human Services has developed and released its Viral Hepatitis National Strategic Plan 2021-2025, which aims to eliminate viral hepatitis i...

see more →

Patient Education  73 results see all →